share_log

成交额TOP20 | 超微电脑收跌7.98%,上半年飙升188%;业绩预期惨淡,耐克重挫20%

Top 20 turnover | Super micro computer fell by 7.98%, skyrocketed by 188% in the first half of the year; performance is expected to be bleak, Nike plummeted by 20%.

環球市場播報 ·  Jun 29 09:54

Nvidia, the top trading volume stock in the US on Friday, fell by 0.36%, with a turnover of 39.37 billion US dollars and a market value maintained above 3 trillion US dollars; Tesla, the second-ranked stock, rose by 0.23%, with a turnover of 19.028 billion US dollars; Apple, the third-ranked stock, fell by 1.63%, with a turnover of 17.553 billion US dollars.

On Friday, the US stock market had the highest trading volume. The stock fell by 0.09%, with a turnover of USD 49.5 billion. The stock has risen more than 10% this week. According to media reports, the US federal regulatory agency has reached an agreement to allow antitrust investigations into Microsoft, OpenAI, and Nvidia's dominant position in the AI industry.$NVIDIA (NVDA.US)$It fell by 0.36%, with a turnover of 39.37 billion US dollars and a market value maintained above 3 trillion US dollars. The stock fell by 2.4% this week, rose by 12.7% in June, and rose by nearly 150% in the first half of the year.

Nvidia's stock price is entering a high-level shock phase, but according to EMJ Capital's hedge fund manager Jackson, if estimated by the expected P/E ratio, Nvidia's stock price is still cheap. He expects Nvidia's stock price to continue to rise, and it is expected to reach $250 at the end of this year-on the basis of the current stock price, which is a doubling of the stock price. If this prediction comes true, Nvidia's market cap will reach a staggering $6 trillion by the end of this year.

The second.$Tesla (TSLA.US)$It rose by 0.23%, with a turnover of 19.028 billion US dollars. Tesla's stock price fell more than 20% in the first half of this year.

Morgan Stanley analyst Adam Jonas maintained a "buy" rating on Tesla with a target price of $310.

The third.$Apple (AAPL.US)$It fell by 1.63%, with a turnover of 17.553 billion US dollars. According to reports, under pressure from European regulatory agencies, Apple is exploring new technologies that allow consumers to replace batteries more easily.

In addition, there have been multiple reports on the internet recently about iPhone 13 battery bulges. In response to this issue, Apple customer service has officially responded that they have received multiple feedbacks about iPhone 13 battery bulges. Engineers believe that this phenomenon may be the result of the combined effects of battery aging and high device temperature in hot weather. Therefore, they recommend users to closely monitor the battery health of their devices.

Ranked fourth.$Amazon (AMZN.US)$It fell by 2.32%, with a turnover of 14.994 billion US dollars. At the Amazon Shenzhen Seller Closed Meeting on June 26th, Amazon announced the addition of a special offer zone on its main site, adopting a fully-managed model (platform responsible for full logistics), and ships from China's warehouses to the United States. Many industry insiders believe that Amazon's entry into the competition of 'low-priced' e-commerce is also a response to the increasingly fierce competition.

Fitch Ratings maintains Amazon's "AA-" rating with a stable outlook.

The fifth.$Super Micro Computer (SMCI.US)$It fell by 7.98%, with a turnover of 13.812 billion US dollars. The stock rose 188% in the first half of this year.

The sixth.$Microsoft (MSFT.US)$It fell by 1.3%, with a turnover of 12.754 billion US dollars. According to reports, the 13 billion US dollar investment deal that Microsoft made to OpenAI, a generative artificial intelligence (AI) company, will be subject to further scrutiny by the EU's antitrust regulators. The EU antitrust regulator is prepared to investigate the incident in which OpenAI has exclusive access to Microsoft cloud technology.

Wells Fargo & Co analyst Michael Turrin maintains a buy rating on Microsoft and a target price of $500.

The seventh.$UnitedHealth (UNH.US)$Lance Wilkes, an analyst at Leumb UFI, maintains a buy rating on UnitedHealth and maintains a target price of $593.

Ranked ninth.$Nike (NKE.US)$It closed down 19.98%, with a turnover of 9.905 billion US dollars, the largest single-day drop in 23 years. Nike's performance expectations for the 2025 fiscal year, which was announced, shocked Wall Street, with at least 6 investment banks downgrading their ratings on the stock. Analysts from Morgan Stanley and Stifel questioned Nike's management, including CEO Donahoe, and said the sports company was losing its once unbreakable reputation. But Nike co-founder Phil Knight told the media that he has full confidence in Donahoe and fully supports him.

Since John Donahoe took over as Nike's CEO in January 2020, the company's stock price has fallen by 25%, far behind the S&P 500 large-cap and retail trade ETF XRT, which have risen 69% and 67% during the same period. In response to the bleak performance outlook released by the global sports giant, major financial institutions on Wall Street have downgraded Nike's stock.

Ranked tenth.$Advanced Micro Devices (AMD.US)$It rose by 1.72%, with a turnover of 9.164 billion US dollars. AMD released the AMD Software Adrenalin driver version 24.6.1 WHQL update on Friday, focusing on supporting two new games, The First Descendant and Once Human.

11th place$Meta Platforms (META.US)$It fell by 2.95%, with a turnover of 8.088 billion US dollars. The company said on Friday that if the Australian government forces Facebook to pay a license fee for displaying links to media channels, it will consider blocking all news content from Facebook, which is consistent with the company's decision to implement similar laws in Canada.

The 12th.$Merck & Co (MRK.US)$It fell by 4.64%, with a turnover of 7.134 billion US dollars. A heavy-duty antibody drug (ADC) jointly developed by Merck and Japan's Daiichi Sankyo, in which Merck has invested heavily, was recently rejected for approval by the US Food and Drug Administration (FDA).

This is a drug called patritumab deruxtecan used to treat non-small cell lung cancer (NSCLC).

ADC is also a biopharmaceutical focus in recent years. Such drugs are called "biological missiles", which can deliver toxic chemotherapy drugs directly to tumors. They are representatives of innovative drugs for precision treatment of tumors.

15th place.$MicroStrategy (MSTR.US)$It fell by 9.7%, with a turnover of 4.778 billion US dollars on Friday. $Bitcoin (BTC.CC)$Falling below $60,000/coin led to a widespread decline in Bitcoin concept stocks. MicroStrategy is the US-listed company with the most Bitcoin holdings.

Editor / jayden

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment